SCHEMBL3135876

SCHEMBL3135876

O=C1S/C(=C/c2ccc(-c3ccccc3)o2)C(=S)N1Cc1ccccc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.55
ALDH1A1 P00352 4/20 0.55
POLB P06746 3/20 0.55
LMNA P02545 3/20 0.55
RAB9A P51151 1/20 0.55
ENPP2 Q13822 2/20 0.54
ITGB2 P05107 2/20 0.53
ITGAM P11215 2/20 0.53
MEN1 O00255 3/20 0.53
RECQL P46063 3/20 0.53
KMT2A Q03164 3/20 0.53
MCL1 Q07820 2/20 0.53
TDP1 Q9NUW8 2/20 0.53
EIF4E P06730 1/20 0.53
EIF4G1 Q04637 1/20 0.53
THRB P10828 1/20 0.53
NPSR1 Q6W5P4 1/20 0.53
ALOX12 P18054 2/20 0.52
EP300 Q09472 1/20 0.50
CREBBP Q92793 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3135883 1.00 MAPT (0.55) MAPTALDH1A1POLBLMNARAB9A
SCHEMBL3135868 1.00 MAPT (0.55) MAPTALDH1A1POLBLMNARAB9A
SCHEMBL3133007 0.87 ITGB2 (0.60) MAPTALDH1A1POLBLMNARAB9A
SCHEMBL3133014 0.87 ITGB2 (0.60) MAPTALDH1A1POLBLMNARAB9A
SCHEMBL3133011 0.87 ITGB2 (0.60) MAPTALDH1A1POLBLMNARAB9A
SCHEMBL3128532 0.86 RAB9A (0.61) MAPTALDH1A1POLBLMNARAB9A
SCHEMBL3128520 0.86 RAB9A (0.61) MAPTALDH1A1POLBLMNARAB9A
SCHEMBL3128525 0.86 RAB9A (0.61) MAPTALDH1A1POLBLMNARAB9A
SCHEMBL3135468 0.85 POLB (0.58) MAPTALDH1A1POLBLMNARAB9A
SCHEMBL3135461 0.85 POLB (0.58) MAPTALDH1A1POLBLMNARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120219613-A1 Novel Antiviral Agents for Enveloped Viruses THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2012-08-30 US claimed
WO-2010044924-A1 NOVEL ANTIVIRAL AGENTS FOR ENVELOPED VIRUSES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2010-04-22 WO claimed
US-20120219613-A1 Novel Antiviral Agents for Enveloped Viruses THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2012-08-30 US disclosed
WO-2010044924-A1 NOVEL ANTIVIRAL AGENTS FOR ENVELOPED VIRUSES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2010-04-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120219613-A1 Novel Antiviral Agents for Enveloped Viruses MAVS, LAMP1, HAVCR2 MAPT 3126/4885ALDH1A1 1264/4885POLB 4238/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.